Your institution may have access to this item. Find your institution then sign in to continue.
Title
Industry Pipeline.
Abstract
The article reports that Allergan has received FDA approval for Restasis Multidose and Xen glaucoma treatment system and Aerie Pharmaceuticals have announced the completion of the patient enrollment in its second phase 3 registration trial.